Treatment for Lower Gastrointestinal Bleeding
The treatment of lower GI bleeding is determined by hemodynamic stability: unstable patients (shock index >1) require immediate CT angiography followed by angioembolization or endoscopy, while stable patients with major bleeding should undergo colonoscopy during hospitalization, and those with minor self-limited bleeding (Oakland score ≤8) can be safely discharged for outpatient investigation. 1
Initial Risk Stratification
First, calculate the shock index (heart rate divided by systolic blood pressure). A shock index >1 defines hemodynamic instability and dictates your entire management pathway 1.
For stable patients, use the Oakland score to categorize bleeding severity:
- Oakland score ≤8 points: Minor, self-terminating bleed—safe for outpatient investigation 1
- Oakland score >8 points: Major bleed—requires hospital admission 1
This risk stratification approach is critical because mortality in LGIB is primarily driven by comorbidities rather than exsanguination, with in-hospital mortality of 3.4% overall but rising to 18% in those who develop bleeding while hospitalized 1.
Management Based on Hemodynamic Status
Unstable Patients (Shock Index >1)
Proceed immediately to CT angiography after initial resuscitation—this is the fastest, least invasive method to localize bleeding before planning intervention 1. The British Society of Gastroenterology provides strong recommendations for this pathway despite low-quality evidence, recognizing the life-threatening nature of unstable LGIB.
Critical pitfall: If CT angiography is positive, catheter angiography with embolization must be performed as soon as possible—ideally within 60 minutes in centers with 24/7 interventional radiology 1. Delays reduce success rates significantly.
If no source is found on CTA: Perform upper endoscopy immediately, as hemodynamically unstable LGIB may actually originate from an upper GI source 1. If the patient stabilizes after resuscitation, gastroscopy may be the first investigation 1.
Emergency laparotomy should be avoided unless every radiological and endoscopic option has been exhausted—this is a strong recommendation reflecting the poor outcomes of blind surgical intervention 1, 2.
Stable Patients with Major Bleeding
Admit for colonoscopy during the hospital stay 1. Importantly, there is no high-quality evidence that early colonoscopy (within 24 hours) improves patient outcomes compared to delayed colonoscopy, so the timing can be flexible based on adequate bowel preparation and patient stability 3.
Colonoscopy serves both diagnostic and therapeutic purposes, allowing for endoscopic hemostasis using injection therapy, hemoclips, thermal coagulation, or band ligation 4, 5.
Stable Patients with Minor Bleeding
Discharge for urgent outpatient investigation if Oakland score ≤8 and no other admission indications exist 1. This is a strong recommendation based on moderate-quality evidence and prevents unnecessary hospitalizations.
Resuscitation and Transfusion Strategy
Blood Transfusion Thresholds
Use a restrictive transfusion strategy in clinically stable patients 1, 6:
- Without cardiovascular disease: Transfuse at Hb ≤70 g/L, target 70-90 g/L post-transfusion 1, 3
- With cardiovascular disease: Transfuse at Hb ≤80 g/L, target ≥100 g/L post-transfusion 1, 3
This restrictive approach is strongly recommended and improves mortality in critically ill patients when using crystalloids for initial resuscitation 7.
Anticoagulation and Antiplatelet Management
Warfarin
Interrupt warfarin immediately at presentation 1. For unstable hemorrhage, reverse with prothrombin complex concentrate and vitamin K (strong recommendation) 1, 3. Fresh frozen plasma is second-line if PCC unavailable 3.
Restart warfarin at 7 days after hemorrhage in patients with low thrombotic risk 1. This timing is based on evidence showing reduced thromboembolism and mortality without increased rebleeding 1.
For high thrombotic risk patients (prosthetic metal mitral valve, AF with prosthetic valve, recent VTE <3 months): Consider bridging with low molecular weight heparin at 48 hours after hemostasis 1.
Direct Oral Anticoagulants (DOACs)
Interrupt DOACs at presentation 1. For life-threatening hemorrhage, use specific reversal agents: idarucizumab for dabigatran or andexanet for factor Xa inhibitors 1, 3.
Restart DOACs at maximum 7 days after hemorrhage, recognizing their rapid onset means full anticoagulation within 3 hours 1.
Antiplatelet Therapy
Aspirin for primary prevention: Permanently discontinue 1
Aspirin for secondary prevention: Do NOT routinely stop. If stopped, restart as soon as hemostasis is achieved or within 5 days 1, 3. A cohort study showed that discontinuing aspirin resulted in fewer rebleeding events but significantly more cardiovascular events and deaths 1.
Dual antiplatelet therapy (aspirin + P2Y12 inhibitor):
- Continue aspirin 1, 3
- P2Y12 inhibitor (clopidogrel) can be temporarily interrupted based on bleeding severity
- Restart P2Y12 inhibitor within 5 days maximum due to high thrombosis risk after this timeframe 1, 3
This 5-day window is based on extensive data from drug-eluting stent studies and represents the optimal balance between hemorrhage and thrombosis risk 1.
Algorithm Summary
- Calculate shock index (HR/SBP)
- If >1 (unstable): CT angiography → angioembolization (within 60 min) or upper endoscopy if negative
- If ≤1 (stable): Calculate Oakland score
- ≤8 points: Discharge for outpatient workup
- >8 points: Admit for colonoscopy during hospitalization
- Transfuse restrictively: Hb trigger 70 g/L (80 g/L if cardiac disease)
- Manage anticoagulation: Reverse if unstable, restart warfarin/DOAC at 7 days
- Manage antiplatelets: Continue aspirin for secondary prevention, restart P2Y12 inhibitor within 5 days